Invesco Aerospace & Defense remains a compelling buy, with accelerating price momentum driven by heightened global defense ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

Explore how differences in sector focus and dividend strategy set these two popular Vanguard ETFs apart for income investors.

Direxion CURE ETF offers 3x daily healthcare exposure—learn risks like volatility decay and drift, plus tactical trading tips using XLV/index signals.

This insider-focused ETF has delivered more than 30% in a year, nearly doubling the S&P 500's return, as investors turn to behavior-driven ETF strategies.

Quality factor investing promises exposure to financially healthy companies with strong balance sheets and consistent ...

Ripple XRP exchange-traded funds (ETFs) saw a surge in volume on July 11, following the market rally that pushed close to $3. Bloomberg senior analyst Eric Balchunas shared the data on X, noting that ...

Led by Cathie Wood, the ARK Innovation ETF (ARKK) is an actively managed exchange-traded fund (ETF) that focuses on finding and investing in Wall Street’s most disruptive companies. Unlike passive ...

Recent discussions on X about the VanEck Semiconductor ETF (SMH) have centered around its impressive performance and potential for future growth, particularly as the semiconductor industry continues ...

Vanguard Extended Market ETF VXF tracks a total market index that excludes S&P 500 stocks. It’s a misfit in the mid-cap blend category, but it pairs well with a fund that tracks the S&P 500 index to ...

Vanguard Small-Cap ETF VB offers a well-diversified, low-turnover portfolio that is representative of the US small-cap market. These features, coupled with a minuscule fee, make it one of the best ...

Eli Lilly And Co (NYSE: LLY) has officially become the giant quietly moving the strings behind a large slice of the pharma ETF universe. With blockbuster revenue growth, repeated earnings beats and a ...